The anti-C5a antibody vilobelimab efficiently inhibits C5a in severe COVID-19 patients
Molecular Immunology
; 141:222-223, 2022.
Article
in English
| Web of Science | ID: covidwho-1801749
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Language:
English
Journal:
Molecular Immunology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS